{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T13:11:38Z","timestamp":1766754698791},"reference-count":38,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.3892\/etm.2016.3086","type":"journal-article","created":{"date-parts":[[2016,2,19]],"date-time":"2016-02-19T04:57:28Z","timestamp":1455857848000},"page":"1788-1794","source":"Crossref","is-referenced-by-count":1,"title":["Immunogenicity of varicella zoster virus glycoprotein E DNA vaccine"],"prefix":"10.3892","volume":"11","author":[{"given":"LIDAO","family":"BAO","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GUOMIN","family":"WEI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HONGMEI","family":"GAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XIANHUA","family":"REN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RUILIAN","family":"MA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YI","family":"WANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HAIJUN","family":"LV","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2016,2,19]]},"reference":[{"key":"key20180108123333_b1-etm-0-0-3086","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/infdis\/jiu500","article-title":"Altered phenotype and functionality of varicella zoster virus-specific cellular immunity in individuals with active infection","volume":"211","author":"Schub","year":"2015","journal-title":"J Infect Dis"},{"key":"key20180108123333_b2-etm-0-0-3086","doi-asserted-by":"crossref","first-page":"39","DOI":"10.5021\/ad.2011.23.1.39","article-title":"Seroepidemiologic survey of varicella-zoster virus in korean adults using glycoprotein enzyme immuno assay and fluorescent antibody to membrane antigen test","volume":"23","author":"Kim","year":"2011","journal-title":"Ann Dermatol"},{"key":"key20180108123333_b3-etm-0-0-3086","doi-asserted-by":"crossref","first-page":"19833","DOI":"10.1074\/jbc.M114.635508","article-title":"Sialic acids on varicella-zoster virus glycoprotein B are required for cell-cell fusion","volume":"290","author":"Suenaga","year":"2015","journal-title":"J Biol Chem"},{"key":"key20180108123333_b4-etm-0-0-3086","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1016\/j.vaccine.2012.01.088","article-title":"Cell-mediated immune responses to a varicella-zoster virus glycoprotein E vaccine using both a TLR agonist and QS21 in mice","volume":"30","author":"Dendouga","year":"2012","journal-title":"Vaccine"},{"key":"key20180108123333_b5-etm-0-0-3086","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1128\/CVI.05061-11","article-title":"Varicella-zoster virus (VZV) glycoprotein E is a serological antigen for detection of intrathecal antibodies to VZV in central nervous system infections, without cross-reaction to herpes simplex virus 1","volume":"18","author":"Grahn","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"key20180108123333_b6-etm-0-0-3086","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jviromet.2011.04.014","article-title":"Recombinant glycoprotein E produced in mammalian cells in large-scale as an antigen for varicella-zoster-virus serology","volume":"175","author":"Thomsson","year":"2011","journal-title":"J Virol Methods"},{"key":"key20180108123333_b7-etm-0-0-3086","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.1128\/JVI.02596-10","article-title":"Mutagenesis of varicella-zoster virus glycoprotein I (gI) identifies a cysteine residue critical for gE\/gI heterodimer formation, gI structure and virulence in skin cells","volume":"85","author":"Oliver","year":"2011","journal-title":"J Virol"},{"key":"key20180108123333_b8-etm-0-0-3086","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1128\/JVI.01902-10","article-title":"Varicella-zoster virus glycoprotein E is a critical determinant of virulence in the SCID mouse-human model of neuropathogenesis","volume":"85","author":"Zerboni","year":"2011","journal-title":"J Virol"},{"key":"key20180108123333_b9-etm-0-0-3086","doi-asserted-by":"crossref","first-page":"417565","DOI":"10.1155\/2015\/417565","article-title":"Transgenic carrot expressing fusion protein comprising M. tuberculosis antigens induces immune response in mice","volume":"2015","author":"Permyakova","year":"2015","journal-title":"Biomed Res Int"},{"key":"key20180108123333_b10-etm-0-0-3086","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1073\/pnas.0912373107","article-title":"Functions of the unique N-terminal region of glycoprotein E in the pathogenesis of varicella-zoster virus infection","volume":"107","author":"Berarducci","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108123333_b11-etm-0-0-3086","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.virol.2009.01.023","article-title":"The insulin degrading enzyme binding domain of varicella-zoster virus (VZV) glycoprotein E is important for cell-to-cell spread and VZV infectivity, while a glycoprotein I binding domain is essential for infection","volume":"386","author":"Ali","year":"2009","journal-title":"Virology"},{"key":"key20180108123333_b12-etm-0-0-3086","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00705-010-0864-0","article-title":"Sequence analysis of the glycoprotein E gene of varicella-zoster virus strains of clades 1, 3 and 5","volume":"156","author":"Sauerbrei","year":"2011","journal-title":"Arch Virol"},{"key":"key20180108123333_b13-etm-0-0-3086","first-page":"334","article-title":"Construction and identification of recombinant eukaryotic plasmid pcDNA3.1(+)-ECH1","volume":"40","author":"Wang","year":"2011","journal-title":"Zhong Hua Bing Li Xue Za Zhi"},{"key":"key20180108123333_b14-etm-0-0-3086","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1021\/mp500835z","article-title":"Targeted microbubbles for ultrasound mediated short hairpin RNA plasmid transfection to inhibit survivin gene expression and induce apoptosis of ovarian cancer A2780\/DDP Cells","volume":"12","author":"Zhang","year":"2015","journal-title":"Mol Pharm"},{"key":"key20180108123333_b15-etm-0-0-3086","doi-asserted-by":"crossref","first-page":"30057","DOI":"10.1074\/jbc.M111.241505","article-title":"Runx2 protein expression utilizes the Runx2 P1 promoter to establish osteoprogenitor cell number for normal bone formation","volume":"286","author":"Liu","year":"2011","journal-title":"J Biol Chem"},{"key":"key20180108123333_b16-etm-0-0-3086","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1128\/CVI.00218-07","article-title":"Rapid, sensitive and specific lateral-flow immunochromatographic point-of-care device for detection of herpes simplex virus type 2-specific immunoglobulin G antibodies in serum and whole blood","volume":"15","author":"Laderman","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"key20180108123333_b17-etm-0-0-3086","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.cca.2011.11.006","article-title":"Surface markers of lymphocyte activation and markers of cell proliferation","volume":"413","author":"Shipkova","year":"2012","journal-title":"Clin Chim Acta"},{"key":"key20180108123333_b18-etm-0-0-3086","doi-asserted-by":"crossref","first-page":"4751","DOI":"10.1128\/JVI.03085-12","article-title":"An attenuated Listeria monocytogenes vector primes more potent simian immunodeficiency virus-specific mucosal immunity than DNA vaccines in mice","volume":"87","author":"Im","year":"2013","journal-title":"J Virol"},{"key":"key20180108123333_b19-etm-0-0-3086","first-page":"114","article-title":"Varicella-zoster virus in children immunized with the varicella vaccine","volume":"90","author":"Chesnut","year":"2012","journal-title":"Cutis"},{"key":"key20180108123333_b20-etm-0-0-3086","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.aca.2012.11.006","article-title":"Current trends in separation of plasmid DNA vaccines: A review","volume":"760","author":"Ghanem","year":"2013","journal-title":"Anal Chim Acta"},{"issue":"Suppl 2","key":"key20180108123333_b21-etm-0-0-3086","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1086\/522127","article-title":"Comparative analyses of the 9 glycoprotein genes found in wild-type and vaccine strains of varicella-zoster virus","volume":"197","author":"Storlie","year":"2008","journal-title":"J Infect Dis"},{"key":"key20180108123333_b22-etm-0-0-3086","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1128\/JVI.00913-08","article-title":"Deletion of the first cysteine-rich region of the varicella-zoster virus glycoprotein E ectodomain abolishes the gE and gI interaction and differentially affects cell-cell spread and viral entry","volume":"83","author":"Berarducci","year":"2009","journal-title":"J Virol"},{"key":"key20180108123333_b23-etm-0-0-3086","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1128\/CVI.00394-12","article-title":"Poor immune responses of newborn rhesus macaques to measles virus DNA vaccines expressing the hemagglutinin and fusion glycoproteins","volume":"20","author":"Polack","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"key20180108123333_b24-etm-0-0-3086","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/1756-3305-5-273","article-title":"Evaluation of protective immune responses induced by DNA vaccines encoding Toxoplasma gondii surface antigen 1 (SAG1) and 14\u20133-3 protein in BALB\/c mice","volume":"5","author":"Meng","year":"2012","journal-title":"Parasit Vectors"},{"key":"key20180108123333_b25-etm-0-0-3086","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.vaccine.2012.10.088","article-title":"Immunisation of mice with Mycoplasma hyopneumoniae antigens P37, P42, P46 and P95 delivered as recombinant subunit or DNA vaccines","volume":"31","author":"Galli","year":"2012","journal-title":"Vaccine"},{"key":"key20180108123333_b26-etm-0-0-3086","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.4161\/hv.22345","article-title":"Harnessing DNA-induced immune responses for improving cancer vaccines","volume":"8","author":"Herrada","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"key20180108123333_b27-etm-0-0-3086","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3389\/fonc.2012.00154","article-title":"Targeted DNA vaccines for enhanced induction of idiotype-specific B and T cells","volume":"2","author":"Fredriksen","year":"2012","journal-title":"Front Oncol"},{"key":"key20180108123333_b28-etm-0-0-3086","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/eji.201242690","article-title":"Three types of human CpG motifs differentially modulate and augment immunogenicity of nonviral and viral replicon DNA vaccines as built-in adjuvants","volume":"43","author":"Yu","year":"2013","journal-title":"Eur J Immunol"},{"key":"key20180108123333_b29-etm-0-0-3086","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1007\/s00253-012-4403-7","article-title":"Improving the safety of viral DNA vaccines: Development of vectors containing both 5\u2032 and 3\u2032 homologous regulatory sequences from non-viral origin","volume":"97","author":"Martinez-Lopez","year":"2013","journal-title":"Appl Microbiol Biotechnol"},{"key":"key20180108123333_b30-etm-0-0-3086","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.vaccine.2012.09.009","article-title":"Comparison of the immune responses in BALB\/c mice following immunization with DNA-based and live attenuated vaccines delivered via different routes","volume":"31","author":"Cai","year":"2013","journal-title":"Vaccine"},{"key":"key20180108123333_b31-etm-0-0-3086","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jbiotec.2012.08.012","article-title":"The future of human DNA vaccines","volume":"162","author":"Li","year":"2012","journal-title":"J Biotechnol"},{"key":"key20180108123333_b32-etm-0-0-3086","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.4161\/hv.21225","article-title":"Preclinical evaluation of the immunogenicity and safety of plasmid DNA-based prophylactic vaccines for human cytomegalovirus","volume":"8","author":"Hartikka","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"key20180108123333_b33-etm-0-0-3086","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.fsi.2012.09.010","article-title":"Construction and analysis of experimental DNA vaccines against megalocytivirus","volume":"33","author":"Zhang","year":"2012","journal-title":"Fish Shellfish Immunol"},{"key":"key20180108123333_b34-etm-0-0-3086","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1016\/j.vaccine.2015.05.007","article-title":"Construction and evaluation of DNA vaccine encoding Hantavirus glycoprotein N-terminal fused with lysosome-associated membrane protein","volume":"33","author":"Jiang","year":"2015","journal-title":"Vaccine"},{"key":"key20180108123333_b35-etm-0-0-3086","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3892\/mmr.2015.3419","article-title":"Immune-enhancing effect of nano-DNA vaccine encoding a gene of the prME protein of Japanese encephalitis virus and BALB\/c mouse granulocyte-macrophage colony-stimulating factor","volume":"12","author":"Zhai","year":"2015","journal-title":"Mol Med Rep"},{"key":"key20180108123333_b36-etm-0-0-3086","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1365-2249.2008.03633.x","article-title":"Varicella zoster virus glycoprotein E-specific CD4+ T cells show evidence of recent activation and effector differentiation, consistent with frequent exposure to replicative cycle antigens in healthy immune donors","volume":"152","author":"Malavige","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"key20180108123333_b37-etm-0-0-3086","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1128\/JCM.01735-07","article-title":"Novel varicella-zoster virus glycoprotein E gene mutations associated with genotypes A and D","volume":"46","author":"Schmidt-Chanasit","year":"2008","journal-title":"J Clin Microbiol"},{"key":"key20180108123333_b38-etm-0-0-3086","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.4161\/hv.21624","article-title":"Non-contact helium-based plasma for delivery of DNA vaccines: Enhancement of humoral and cellular immune responses","volume":"8","author":"Connolly","year":"2012","journal-title":"Hum Vaccin Immunother"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/etm.2016.3086\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T16:49:41Z","timestamp":1515430181000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/etm.2016.3086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,19]]},"references-count":38,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,2,19]]},"published-print":{"date-parts":[[2016,5]]}},"alternative-id":["10.3892\/etm.2016.3086"],"URL":"https:\/\/doi.org\/10.3892\/etm.2016.3086","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,19]]}}}